Artificial intelligence is swiftly evolving, forcing regulators to figure out how to oversee a technology that can act autonomously and potentially improve itself, experts said at the HIMSS conference in Las Vegas.
AI is moving at lightning speed. Can regulation keep up? Read More »
The move comes as BioNTech shifts to being a multiproduct commercial biotech, allowing Ugur Sahin and Özlem Türeci to transition back into research on next-generation mRNA therapeutics.
BioNTech Founders To Leave Famed mRNA Biotech for New Venture Read More »
Stylus Medicine, a member of BioSpace’s NextGen Class of 2026, launched in May 2025 to develop new, less complex genetic medicines. The company’s in vivo approach has attracted “intense” interest from Big Pharma.
Rising Amid Flurry of CAR T Deals, Stylus Proves Cell Therapy Is Not Dead Read More »
Breakout Ventures’ focus on early-stage companies stands out as more and more investors elect to save their dollars for derisked assets.
AI-Focused Fund Breakout Raises $114M To Support Early-Stage Biotechs Read More »
Analysts expect the market for manufacturing cell and gene therapies, worth less than $20 billion in 2024, to expand rapidly as approvals drive higher volumes of production.
Cell and Gene Therapy Manufacturing Market To Skyrocket to $146B by 2032 Read More »
El 14 de marzo se celebra el Día Mundial del Sueño en un escenario preocupante para la población española. Según datos difundidos por la Sociedad Española de Neurología (SEN), menos del 50% de la población duerme las horas recomendada …
Sueño, salud y trabajo: la guía de Quirón Prevención para dormir mejor Read More »
Dyne Therapeutics is plotting an approval application for z-rostudirsen in the back half of 2026—a push that will only be bolstered by the departure of controversial CBER chief Vinay Prasad, according to analysts at Stifel.
La obesidad es un problema importante de salud pública que se ha convertido en una de las principales causas de muerte en los países con ingresos económicos altos. La obesidad en personas adultas a nivel mundial es más de tres veces mayor que en 1975, según la Orga …
Dudas sobre la eficacia del ayuno intermitente para adelgazar Read More »
Los humanos anatómicamente modernos tenemos bajos niveles de ascendencia neandertal, pero, de todos modos, esta ascendencia no se distribuye de forma uniforme en la población mundial. Cuando se comparan los genomas de neandertales con los de humanos modernos, se revelan diferencias not …
Vertex Pharmaceuticals has a rolling biologics license application with the FDA for povetaciceptin IgA nephropathy. With new data from RAINIER, the biotech expects to complete its submission by the end of March.
Vertex’s Nephropathy Asset Delivers ‘Strong’ Late-Stage Data, Clears Path to FDA Read More »
